Abstract:The extracellular matrix is a richly bioactive composition of substrates that provides biophysical stability, facilitates intercellular signaling, and both reflects and governs the physiological status of the local microenvironment. The matrix in the central nervous system (CNS) is far from simply an inert scaffold for mechanical support, instead conducting an active role in homeostasis and providing broad capacity for adaptation and remodeling in response to stress that otherwise would challenge equilibrium between neuronal, glial, and vascular elements. A major constituent is collagen, whose characteristic triple helical structure renders mechanical and biochemical stability to enable bidirectional crosstalk between matrix and resident cells. Multiple members of the collagen superfamily are critical to neuronal maturation and circuit formation, axon guidance, and synaptogenesis in the brain. In mature tissue, collagen interacts with other fibrous proteins and glycoproteins to sustain a three-dimensional medium through which complex networks of cells can communicate. While critical for matrix scaffolding, collagen in the CNS is also highly dynamic, with multiple binding sites for partnering matrix proteins, cell-surface receptors, and other ligands. These interactions are emerging as critical mediators of CNS disease and injury, particularly regarding changes in matrix stiffness, astrocyte recruitment and reactivity, and pro-inflammatory signaling in local microenvironments. Changes in the structure and/or deposition of collagen impact cellular signaling and tissue biomechanics in the brain, which in turn can alter cellular responses including antigenicity, angiogenesis, gliosis, and recruitment of immune-related cells. These factors, each involving matrix collagen, contribute to the limited capacity for regeneration of CNS tissue. Emerging therapeutics that attempt to rebuild the matrix using peptide fragments, including collagen-enriched scaffolds and mimetics, hold great potential to promote neural repair and regeneration. Recent evidence from our group and others indicates that repairing protease-degraded collagen helices with mimetic peptides helps restore CNS tissue and promote neuronal survival in a broad spectrum of degenerative conditions. Restoration likely involves bolstering matrix stiffness to reduce the potential for astrocyte reactivity and local inflammation as well as repairing inhibitory binding sites for immune-signaling ligands. Facilitating repair rather than endogenous replacement of collagen degraded by disease or injury may represent the next frontier in developing therapies based on protection, repair, and regeneration of neurons in the central nervous system.

Unraveling the Nexus: The Role of Collapsin Response Mediator Protein 2 Phosphorylation in Neurodegeneration and Neuroregeneration

Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications

The Regulatory and Enzymatic Functions of CRMPs in Neuritogenesis, Synaptic Plasticity, and Gene Transcription.

Protease Regulation: the Yin and Yang of Neural Development and Disease

CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases

Inhibition of CRMP2 Phosphorylation Suppresses Microglia Activation in the Retina and Optic Nerve and Promotes Optic Nerve Regeneration After Optic Nerve Injury

CRMP2 Participates in Regulating Mitochondrial Morphology and Motility in Alzheimer's Disease

Camkii Phosphorylates Collapsin Response Mediator Protein 2 and Modulates Axonal Damage During Glutamate Excitotoxicity

Regulation of neurite outgrowth by collapsin response mediator proteins in neurons

Distribution of different phosphorylated forms of CRMP2 in hippocampal neurons and their effect on neurites growth of hippocampal neurons in rats

Calcium-Associated Proteins in Neuroregeneration

Global Analysis of Neuronal Phosphoproteome Regulation by Chondroitin Sulfate Proteoglycans.

Tat-Collapsin Response Mediator Protein 2 (CRMP2) Increases the Survival of Neurons After NMDA Excitotoxity by Reducing the Cleavage of CRMP2

Collagen in the central nervous system: contributions to neurodegeneration and promise as a therapeutic target

Permissive and Repulsive Cues and Signalling Pathways of Axonal Outgrowth and Regeneration

The Involvement of CRMP-2 on Axonal and Dendrictic Injury after Hypoxic-Ischemic Brain Injury in Neonatal Rat]

Modulating mitochondrial calcium channels (TRPM2/MCU/NCX) as a therapeutic strategy for neurodegenerative disorders

The Extracellular Signal-Regulated Kinase 1/2 Pathway in Neurological Diseases: A Potential Therapeutic Target (Review)

Regulation of AMPAR trafficking in synaptic plasticity by BDNF and the impact of neurodegenerative disease

[CRMP2 binding compound accelerates functional recovery from central nervous system damage]